Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kostenuik

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Oncology|May 17, 2011
Increased expression of C-myc messenger-RNA and protein in walker 256 cancer-cells stimulated by bone-derived conditioned media and by transforming-growth-factor-Beta (tgf-Beta)P Kostenuik, F Orr, L Arsenault, et al.
Clinical Orthopaedics and Related Research|March 1, 1995
Tumor-bone interactions in skeletal metastasisF W Orr, O H Sanchez-Sweatman, P Kostenuik, et al.
Breast Cancer Research and Treatment|January 1, 1993
Mechanisms involved in the metastasis of cancer to boneF W Orr, P Kostenuik, O H Sanchez-Sweatman, et al.
Critical Reviews in Eukaryotic Gene Expression|March 29, 2001
Mechanisms of tumor metastasis to boneM H Weber, D Goltzman, P Kostenuik, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 9, 1998
Lack of effect of spaceflight on bone mass and bone formation in group-housed ratsT J Wronski, M Li, Y Shen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosisB Bolon, C Carter, M Daris, et al.
Calcified Tissue International|December 20, 2005
The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidismJ Padagas, M Colloton, V Shalhoub, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 14, 2011
OPG-Fc treatment in growing pigs leads to rapid reductions in bone resorption markers, serum calcium, and bone formation markersW Sipos, P Zysset, P Kostenuik, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolismJ Li, I Sarosi, X Q Yan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Oncology|May 17, 2011
Increased expression of C-myc messenger-RNA and protein in walker 256 cancer-cells stimulated by bone-derived conditioned media and by transforming-growth-factor-Beta (tgf-Beta)P Kostenuik, F Orr, L Arsenault, et al.
Clinical Orthopaedics and Related Research|March 1, 1995
Tumor-bone interactions in skeletal metastasisF W Orr, O H Sanchez-Sweatman, P Kostenuik, et al.
Breast Cancer Research and Treatment|January 1, 1993
Mechanisms involved in the metastasis of cancer to boneF W Orr, P Kostenuik, O H Sanchez-Sweatman, et al.
Critical Reviews in Eukaryotic Gene Expression|March 29, 2001
Mechanisms of tumor metastasis to boneM H Weber, D Goltzman, P Kostenuik, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 9, 1998
Lack of effect of spaceflight on bone mass and bone formation in group-housed ratsT J Wronski, M Li, Y Shen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosisB Bolon, C Carter, M Daris, et al.
Calcified Tissue International|December 20, 2005
The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidismJ Padagas, M Colloton, V Shalhoub, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 14, 2011
OPG-Fc treatment in growing pigs leads to rapid reductions in bone resorption markers, serum calcium, and bone formation markersW Sipos, P Zysset, P Kostenuik, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolismJ Li, I Sarosi, X Q Yan, et al.
Pageof 1